Clinical Trial Update: Edaravone and Dexborneol Sublingual Tablet for Treating Chemotherapy- Induced Cognitive Impairment Study [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is recruiting to evaluate the combination of edaravone and dexborneol sublingual tablets for chemotherapy-induced cognitive impairment …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Cognitive Impairment

Drugs mentioned

• Dexborneol Sublingual Tablet (dexborneol)
• Edaravone (Edaravone)

Snippet

Sponsor: Chuansheng Zhao | Conditions: Chemo Brain | Phase 4 | Status: RECRUITING